Letaplimab (Anti-CD47)

Letaplimab (Anti-CD47) is a human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. MW : 142.88 KD.

Price Not Available 1mg*25 Letaplimab (Anti-CD47) Supplier Page
Trivial name IBI-188
Catalog Number A2824
CAS# 2283356-07-8
Size 1mg*25